Thursday, April 2, 2015

Alere i Strep A test receives marketing clearance from FDA

Alere Inc. (NYSE: ALR), a global leader in rapid diagnostic tests, today announced that its Alere™ i Strep A test has received marketing clearance from the U.S. Food and Drug Administration (FDA). Alere i Strep A is the first molecular test that detects ... ..

via News Feed

No comments:

Post a Comment